Live Breaking News & Updates on Works Therapeutics

Stay updated with breaking news from Works therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

73,949 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Acquired by Monashee Investment Management LLC

Monashee Investment Management LLC purchased a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 73,949 shares of the company’s stock, valued at approximately $2,699,000. SpringWorks Therapeutics makes up about […] ....

United States , Monashee Investment Management , Charles Schwab Investment Management Inc , Exchange Commission , Victory Capital Management Inc , Jpmorgan Chase Co , Norges Bank , Springworks Therapeutics Inc , Mutual Of America Capital Management , Walleye Capital , Springworks Therapeutics , Free Report , Works Therapeutics , Capital Management , Schwab Investment Management , America Capital Management , Get Free Report , Visit Holdingschannel , Springworks Therapeutics Daily ,

How a 28-Year-Old Woman Kept Her Sense of Adventure Following a Rare Disease Diagnosis

(BPT) - In 2018, a vibrant young woman with a passion for theater and education set off on the quest of a lifetime: spending a month walking 500 miles on the Camino de Santiago pilgrimage from France … ....

Springworks Therapeutics Inc , Cancer Research , Drug Administration , Cactus Cancer Society , National Cancer Institute Center , Camino De Santiago , Springworks Therapeutics , Important Safety Information , Girl Meets Cancer Instagram , Prescribing Information , Dei Tos , Soft Tissue Tumours , Cancer Institute Center , Accessed August , Support Care , Mayo Clinic , Works Therapeutics ,

Analyzing MiNK Therapeutics (NASDAQ:INKT) and SpringWorks Therapeutics (NASDAQ:SWTX)

MiNK Therapeutics (NASDAQ:INKT – Get Free Report) and SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Valuation & Earnings This table compares MiNK Therapeutics […] ....

United States , New York , Katholieke Universiteit Leuven , Agenus Inc , Mink Therapeutics Inc , Flanders Institute For Biotechnology , Dana Farber Cancer Institute , Springworks Therapeutics Inc , Beigene Ltd , Agentus Therapeutics Inc , Pfizer Inc , Get Free Report , Springworks Therapeutics , Springworks Therapeutic , Agentus Therapeutics , Works Therapeutics , Flanders Institute , Epidermal Growth Factor ,

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Samantha Hilson Sandler , Christopherl Moertel , Betty Jayne Dahlberg , Jim Cassidy , University Of Minnesota School Medicine , Clinical Research Division , American Society Of Clinical Oncology , Fred Hutchinson Cancer Center , Children Tumor Foundation , European Medicines Agency , Health Supervision For Children With Neurofibromatosis Type , Neurofibromatosis Program , Drug Administration , Springworks Therapeutics Inc , Desmoid Tumor Working Group , University Of Washington , Us Department Of Commerce , European Commission , Works Therapeutics , Clinical Oncology , Annual Meeting , Chief Medical Officer , Oral Presentations , Numeric Rating , Medical Director ,

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of ...

– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation – ....

United States , Christopherl Moertel , Betty Jayne Dahlberg , Jim Cassidy , Samantha Hilson Sandler , University Of Washington , Children Tumor Foundation , Neurofibromatosis Program , Fred Hutchinson Cancer Center , Health Supervision For Children With Neurofibromatosis Type , European Commission , Clinical Research Division , Springworks Therapeutics Inc , European Medicines Agency , Us Department Of Commerce , American Society Of Clinical Oncology , University Of Minnesota School Medicine , Drug Administration , Desmoid Tumor Working Group , Works Therapeutics , Clinical Oncology , Annual Meeting , Chief Medical Officer , Oral Presentations , Numeric Rating , Medical Director ,